|
|
||||||||
-Induced Sphingosine 1-Phosphate Inhibits Apoptosis Through a Phosphatidylinositol 3-Kinase/Akt Pathway in Human Hepatocytes1




*
First Department of Internal Medicine and
Department of Biochemistry, Gifu University School of Medicine, Gifu, Japan;
Departments of Medicine, Biochemistry, and Biophysics, University of North Carolina, Chapel Hill, NC 27599; and
Gifu International Institute of Biotechnology, Institute of Applied Biochemistry, Gifu, Japan
Human hepatocytes usually are resistant to TNF-
cytotoxicity. In
mouse or rat hepatocytes, repression of NF-
B activation is
sufficient to induce TNF-
-mediated apoptosis. However, in both Huh-7
human hepatoma cells and Hc human normal hepatocytes, when infected
with an adenovirus expressing a mutated form of I
B
(Ad5I
B),
which almost completely blocks NF-
B activation, >80% of the cells
survived 24 h after TNF-
stimulation. Here, we report that
TNF-
activates other antiapoptotic factors, such as sphingosine
kinase (SphK), phosphatidylinositol 3-kinase (PI3K), and Akt kinase.
Pretreatment of cells with N,N-dimethylsphingosine
(DMS), an inhibitor of SphK, or LY 294002, an inhibitor of PI3K that
acts upstream of Akt, increased the number of apoptotic cells induced
by TNF-
in Ad5I
B-infected Huh-7 and Hc cells. TNF-
-induced
activations of PI3K and Akt were inhibited by DMS. In contrast,
exogenous sphingosine 1-phosphate, a product of SphK, was found to
activate Akt and partially rescued the cells from TNF-
-induced
apoptosis. Although Akt has been reported to activate NF-
B, DMS and
LY 294002 failed to prevent TNF-
-induced NF-
B activation,
suggesting that the antiapoptotic effects of SphK and Akt are
independent of NF-
B. Furthermore, apoptosis mediated by Fas ligand
(FasL) involving Akt activation also was potentiated by DMS
pretreatment in Hc cells. Sphingosine 1-phosphate administration
partially protected cells from FasL-mediated apoptosis. These results
indicate that not only NF-
B but also SphK and PI3K/Akt are involved
in the signaling pathway(s) for protection of human hepatocytes from
the apoptotic action of TNF-
and probably FasL.
This article has been cited by other articles:
![]() |
S. Nemoto, M. Nakamura, Y. Osawa, S. Kono, Y. Itoh, Y. Okano, T. Murate, A. Hara, H. Ueda, Y. Nozawa, et al. Sphingosine Kinase Isoforms Regulate Oxaliplatin Sensitivity of Human Colon Cancer Cells through Ceramide Accumulation and Akt Activation J. Biol. Chem., April 17, 2009; 284(16): 10422 - 10432. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wadgaonkar, V. Patel, N. Grinkina, C. Romano, J. Liu, Y. Zhao, S. Sammani, J. G. N. Garcia, and V. Natarajan Differential regulation of sphingosine kinases 1 and 2 in lung injury Am J Physiol Lung Cell Mol Physiol, April 1, 2009; 296(4): L603 - L613. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, H.-Y. Guan, L.-Y. Gong, L.-B. Song, N. Zhang, J. Wu, J. Yuan, Y.-J. Zheng, Z.-S. Huang, and M. Li Clinical Significance of Sphingosine Kinase-1 Expression in Human Astrocytomas Progression and Overall Patient Survival Clin. Cancer Res., November 1, 2008; 14(21): 6996 - 7003. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. N. Jackson, S. D. Larson, S. R. Silva, P. G. Rychahou, L. A. Chen, S. Qiu, S. Rajaraman, and B. M. Evers PI3K/Akt activation is critical for early hepatic regeneration after partial hepatectomy Am J Physiol Gastrointest Liver Physiol, June 1, 2008; 294(6): G1401 - G1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nishikawa, K. Hagihara, S. Serada, T. Isobe, A. Matsumura, J. Song, T. Tanaka, I. Kawase, T. Naka, and K. Yoshizaki Transcriptional Complex Formation of c-Fos, STAT3, and Hepatocyte NF-1{alpha} Is Essential for Cytokine-Driven C-Reactive Protein Gene Expression J. Immunol., March 1, 2008; 180(5): 3492 - 3501. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Radeff-Huang, T. M. Seasholtz, J. W. Chang, J. M. Smith, C. T. Walsh, and J. H. Brown Tumor Necrosis Factor-{alpha}-stimulated Cell Proliferation Is Mediated through Sphingosine Kinase-dependent Akt Activation and Cyclin D Expression J. Biol. Chem., January 12, 2007; 282(2): 863 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. He, H. Suzuki, N. Sharma, and R. P. Sharma Ceramide Synthase Inhibition by Fumonisin B1 Treatment Activates Sphingolipid-Metabolizing Systems in Mouse Liver Toxicol. Sci., December 1, 2006; 94(2): 388 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Bharhani, R. Borojevic, S. Basak, E. Ho, P. Zhou, and K. Croitoru IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression. Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G820 - G829. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. French, J. J. Upson, S. N. Keller, Y. Zhuang, J. K. Yun, and C. D. Smith Antitumor Activity of Sphingosine Kinase Inhibitors J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 596 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-H. Huang and S. L. Morrison A Trimeric Anti-HER2/neu ScFv and Tumor Necrosis Factor-{alpha} Fusion Protein Induces HER2/neu Signaling and Facilitates Repair of Injured Epithelia J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 983 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Le Scolan, D. Pchejetski, Y. Banno, N. Denis, P. Mayeux, W. Vainchenker, T. Levade, and F. Moreau-Gachelin Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression Blood, September 1, 2005; 106(5): 1808 - 1816. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Osawa, H. Uchinami, J. Bielawski, R. F. Schwabe, Y. A. Hannun, and D. A. Brenner Roles for C16-ceramide and Sphingosine 1-Phosphate in Regulating Hepatocyte Apoptosis in Response to Tumor Necrosis Factor-{alpha} J. Biol. Chem., July 29, 2005; 280(30): 27879 - 27887. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D'Alessio, R. S. Al-Lamki, J. R. Bradley, and J. S. Pober Caveolae Participate in Tumor Necrosis Factor Receptor 1 Signaling and Internalization in a Human Endothelial Cell Line Am. J. Pathol., April 1, 2005; 166(4): 1273 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Pitson, P. Xia, T. M. Leclercq, P. A.B. Moretti, J. R. Zebol, H. E. Lynn, B. W. Wattenberg, and M. A. Vadas Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling J. Exp. Med., January 3, 2005; 201(1): 49 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Reiss, B. Oskouian, J. Zhou, V. Gupta, P. Sooriyakumaran, S. Kelly, E. Wang, A. H. Merrill Jr., and J. D. Saba Sphingosine-phosphate Lyase Enhances Stress-induced Ceramide Generation and Apoptosis J. Biol. Chem., January 9, 2004; 279(2): 1281 - 1290. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. PETTUS, J. BIELAWSKI, A. M. PORCELLI, D. L. REAMES, K. R. JOHNSON, J. MORROW, C. E. CHALFANT, L. M. OBEID, and Y. A. HANNUN The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-{alpha} FASEB J, August 1, 2003; 17(11): 1411 - 1421. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshimoto, M. Furuhata, S. Kamiya, M. Hisada, H. Miyaji, Y. Magami, K. Yamamoto, H. Fujiwara, and J. Mizuguchi Positive Modulation of IL-12 Signaling by Sphingosine Kinase 2 Associating with the IL-12 Receptor {beta}1 Cytoplasmic Region J. Immunol., August 1, 2003; 171(3): 1352 - 1359. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Silins, M. Nordstrand, J. Hogberg, and U. Stenius Sphingolipids suppress preneoplastic rat hepatocytes in vitro and in vivo Carcinogenesis, June 1, 2003; 24(6): 1077 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Osawa, M. Nagaki, Y. Banno, D. A. Brenner, Y. Nozawa, H. Moriwaki, and S. Nakashima Expression of the NF-{kappa}B Target Gene X-Ray-Inducible Immediate Early Response Factor-1 Short Enhances TNF-{alpha}-Induced Hepatocyte Apoptosis by Inhibiting Akt Activation J. Immunol., April 15, 2003; 170(8): 4053 - 4060. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Grey, Q. Chen, K. Callon, X. Xu, I. R. Reid, and J. Cornish The Phospholipids Sphingosine-1-Phosphate and Lysophosphatidic Acid Prevent Apoptosis in Osteoblastic Cells via a Signaling Pathway Involving Gi Proteins and Phosphatidylinositol-3 Kinase Endocrinology, December 1, 2002; 143(12): 4755 - 4763. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Osawa, M. Nagaki, Y. Banno, D. A. Brenner, T. Asano, Y. Nozawa, H. Moriwaki, and S. Nakashima Tumor Necrosis Factor Alpha-Induced Interleukin-8 Production via NF-{kappa}B and Phosphatidylinositol 3-Kinase/Akt Pathways Inhibits Cell Apoptosis in Human Hepatocytes Infect. Immun., November 1, 2002; 70(11): 6294 - 6301. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Davaille, L. Li, A. Mallat, and S. Lotersztajn Sphingosine 1-Phosphate Triggers Both Apoptotic and Survival Signals for Human Hepatic Myofibroblasts J. Biol. Chem., September 27, 2002; 277(40): 37323 - 37330. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Vann, S. G. Payne, L. C. Edsall, S. Twitty, S. Spiegel, and S. Milstien Involvement of Sphingosine Kinase in TNF-alpha -stimulated Tetrahydrobiopterin Biosynthesis in C6 Glioma Cells J. Biol. Chem., April 5, 2002; 277(15): 12649 - 12656. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |